Soheila Hosseinzadeh | Cognitive Neuroscience | Best Researcher Award

Published on by Neuroscientists

Assoc. Prof. Dr. Soheila Hosseinzadeh | Cognitive Neuroscience | Best Researcher Award

Assist. Prof. Dr. Soheila Hosseinzadeh, Tehran University of Medical Sciences, Iran.

Dr. Soheila Hosseinzadeh is a distinguished Assistant Professor of Neuroscience at the Tehran University of Medical Sciences, with a rich academic background that spans nursing, physiology, and neuroscience. Over the years, she has made substantial contributions to neuroscience education and research, particularly in the fields of cognitive neurophysiology and addiction studies. Her expertise includes a wide range of advanced techniques such as event-related potential analysis, EEG-based neurofeedback, behavioral studies, and molecular tools like RT-PCR and ELISA. She has played a pivotal role in training students and developing neuroscience programs at multiple academic institutions, demonstrating a balanced commitment to both teaching and scientific innovation.

Academic Profile

Google Scholar

Early Academic Pursuits

Dr. Soheila Hosseinzadeh’s academic foundation is deeply rooted in an interdisciplinary understanding of human physiology and neurological sciences. Her early career began with a Bachelor of Science in Nursing in 2000, which was soon followed by a Master’s degree in Physiology in 2003. Demonstrating a keen interest in the mechanisms underlying brain function and behavior, she further advanced her expertise by earning a Ph.D. in Neuroscience in 2013. These academic milestones laid a solid groundwork for her future in teaching and cutting-edge neurophysiological research.

Professional Endeavors in Neuroscience

After completing her Ph.D., Dr. Hosseinzadeh embarked on an academic and research-oriented career that has spanned over a decade. From 2014 to April 2022, she served as a neurophysiology course instructor at Babol University of Medical Sciences, nurturing future scientists with her in-depth understanding of brain physiology. Since April 2022, she has continued her academic contributions at the Tehran University of Medical Sciences, where she teaches courses in Neuroscience and Addiction Studies. Her dual role as educator and researcher places her at the forefront of neuroscience education in Iran.

Contributions and Research Focus

Dr. Hosseinzadeh’s research is focused on the interface of cognitive neuroscience and addiction studies. Her technical proficiency includes advanced neurophysiological techniques such as event-related potential (ERP) recording and analysis, quantitative EEG (QEEG)-based neurofeedback, and behavioral assessments in animal models. She is also experienced in molecular biology tools including real-time RT-PCR and ELISA, alongside rodent stereotaxic surgeries and flow cytometry. Her work often explores neural mechanisms underlying cognitive functions, brain plasticity, and responses to addictive substances—bridging lab findings with clinical relevance.

Accolades and Recognition

Throughout her academic journey, Dr. Hosseinzadeh has earned recognition for her expertise in neurophysiological and behavioral science. Her dual roles at prestigious institutions such as Tehran University of Medical Sciences reflect her trusted authority in the field. While her accolades are more rooted in impact and mentorship than in public awards, her consistent engagement in neuroscience education and translational research is a clear indicator of peer acknowledgment and professional respect.

Impact and Influence

Dr. Hosseinzadeh’s influence extends beyond academic teaching. By integrating theoretical neuroscience with hands-on technical applications like neurofeedback and EEG-based cognitive training, she fosters a research culture that promotes both clinical innovation and scientific discovery. Her guidance has shaped students and young researchers in multiple universities, many of whom continue to advance the fields of neurophysiology and cognitive rehabilitation across the country.

Legacy in Neurotechnology and Cognitive Health

Her pioneering efforts in cognitive task design and ERP analysis have significantly contributed to Iran’s growing reputation in brain research. As one of the few experts integrating neurofeedback with behavioral science and electrophysiology, Dr. Hosseinzadeh has helped establish a platform for neurotechnological interventions in addiction and mental health studies. Her legacy lies in creating an interdisciplinary approach that merges neuroscientific inquiry with practical healthcare applications.

Future Contributions and Vision

Looking ahead, Dr. Soheila Hosseinzadeh is poised to make even greater strides in neuroscience, particularly in the domains of addiction neurobiology, cognitive rehabilitation, and neurofeedback therapy. With continuous advancements in brain-monitoring tools and behavioral modeling, she aims to lead research projects that offer deeper insights into brain-behavior relationships and provide innovative treatments for neuropsychiatric disorders. Her vision includes developing collaborative research networks that connect Iranian neuroscience to global scientific conversations.

Publication

Piperine restores streptozotocin-induced cognitive impairments: Insights into oxidative balance in cerebrospinal fluid and hippocampus
M Khalili-Fomeshi, MG Azizi, MR Esmaeili, M Gol, S Kazemi, …
2018

Plasma microparticles in Alzheimer’s disease: The role of vascular dysfunction
S Hosseinzadeh, M Noroozian, E Mortaz, K Mousavizadeh
2018

Elevated CSF and plasma microparticles in a rat model of streptozotocin-induced cognitive impairment
S Hosseinzadeh, M Zahmatkesh, MR Zarrindast, GR Hassanzadeh, …
2013

Effect of methamphetamine exposure on the plasma levels of endothelial-derived microparticles
A Nazari, M Zahmatkesh, E Mortaz, S Hosseinzadeh
2018

Hippocampal DHCR24 down regulation in a rat model of streptozotocin-induced cognitive decline
S Hosseinzadeh, M Zahmatkesh, M Heidari, GR Hassanzadeh, …
2015

Increment of CSF fractalkine-positive microvesicles preceded the spatial memory impairment in amyloid beta neurotoxicity
L Karimi-Zandi, M Zahmatkesh, G Hassanzadeh, S Hosseinzadeh
2022

Arbutin intervention ameliorates memory impairment in a rat model of lysolecethin induced demyelination: Neuroprotective and anti-inflammatory effects
S Ashrafpour, MJ Nasr-Taherabadi, A Sabouri-Rad, S Hosseinzadeh, …
2024

Conclusion

Dr. Hosseinzadeh’s career reflects an exemplary blend of academic excellence, technical expertise, and visionary research in neuroscience. Her efforts have significantly advanced the understanding of brain function, particularly in the context of addiction and cognitive health. As a leader in her field, she continues to inspire the next generation of neuroscientists while actively contributing to translational research that bridges laboratory findings with clinical solutions. With her ongoing work and future vision, Dr. Hosseinzadeh stands out as a key figure in shaping the future of neuroscience in Iran and beyond.

Mona Fikry | Cognitive Neuroscience | Best Academic Researcher Award

Published on by Neuroscientists

Assist. Prof. Dr. Mona Fikry | Cognitive Neuroscience | Best Academic Researcher Award

Assist. Prof. Dr.  Mona Fikry, Faculty of Pharmacy-Cairo University, Egypt.

Dr. Mona Fikry Said, Assistant Professor of Pharmaceutical Chemistry at Cairo University, stands out as a dedicated educator, researcher, and mentor in the field of medicinal chemistry. Her academic journey reflects a blend of deep scientific knowledge and practical teaching expertise. She has supervised numerous postgraduate theses and published extensively in prestigious journals. Her research, particularly in the synthesis and pharmacological evaluation of novel compounds for neurodegenerative diseases, highlights her commitment to addressing real-world health challenges. Beyond her publications, Dr. Said’s influence extends through academic collaboration, curriculum development, and mentorship.

Profile

Google Scholar

🎓 Early Academic Pursuits

Dr. Mona Fikry Said began her academic journey with a strong foundation in pharmaceutical sciences, eventually channeling her passion for medicinal chemistry into advanced academic and research endeavors. Her early commitment to learning laid the groundwork for a career dedicated to both academic excellence and scientific innovation. This formative stage was marked by rigorous study and a growing interest in drug design and discovery, which shaped her professional focus.

🧪 Professional Endeavors

Currently serving as an Assistant Professor of Pharmaceutical Chemistry at the Faculty of Pharmacy, Cairo University, Dr. Said has become a respected educator and mentor in her field. She has been actively involved in teaching a wide array of pharmaceutical chemistry courses and guiding numerous master’s and doctoral students through their theses. Her role extends beyond instruction, as she also participates in academic advising and serves as an external examiner for other institutions.

🔬 Contributions and Research Focus

Dr. Said’s research is deeply rooted in pharmaceutical chemistry, with a particular focus on the development of novel bioactive compounds. Her most recent completed project, “Probing new 3-hydrazinyl indole phenacetamide derivatives as multitarget anti-Alzheimer: Synthesis, in vivo, in vitro, and in silico studies,” exemplifies her multidisciplinary approach to drug discovery. She integrates synthesis, pharmacological testing, and computational modeling to explore new therapeutic avenues, especially for neurodegenerative diseases.

🏅 Accolades and Recognition

While not always publicly documented, Dr. Said’s scientific contributions are widely acknowledged through her publications in high-impact journals such as European Journal of Medicinal Chemistry, Molecular Diversity, Bioorganic Chemistry, and Future Medicinal Chemistry. Her expertise is recognized by her academic peers, and her involvement in national academic programs highlights her standing in the pharmaceutical education community.

🌐 Impact and Influence

Through her publications in SCI and Scopus-indexed journals, Dr. Said has significantly contributed to the body of knowledge in pharmaceutical chemistry. Her work bridges theoretical research and practical applications, influencing both the academic landscape and the early stages of pharmaceutical development. By mentoring postgraduate students and collaborating across institutions, she has helped cultivate a new generation of researchers in Egypt and beyond.

📘 Legacy and Future Contributions

Dr. Said’s lasting impact lies not only in her research but also in her educational leadership. With each class she teaches and each thesis she supervises, she sows the seeds for future advancements in medicinal chemistry. Her continued involvement in clinical academic programs and university examinations ensures that her influence will resonate across institutions for years to come. Looking forward, her research aims to expand into more diverse therapeutic targets, further strengthening Cairo University’s role in pharmaceutical innovation.

🧬 Research Vision in Pharmaceutical Chemistry

With an enduring commitment to discovery, Dr. Mona Fikry Said envisions a research future driven by interdisciplinary collaboration and the integration of cutting-edge techniques. Her dedication to the design and synthesis of multitarget agents reflects a broader mission to combat complex diseases like Alzheimer’s. In doing so, she positions herself at the forefront of modern pharmaceutical chemistry, where innovation and impact go hand in hand.

Publication

  • Synthesis of novel 1,3,4-trisubstituted pyrazoles as anti-inflammatory and analgesic agents
    FA Ragab, NMA Gawad, HH Georgey, MF Said
    2013

 

  • Design and synthesis of ibuprofen-quinoline conjugates as potential anti-inflammatory and analgesic drug candidates
    AM Ghanim, AS Girgis, BM Kariuki, N Samir, MF Said, A Abdelnaser, …
    2022

 

  • Pyrazolone derivatives: Synthesis, anti-inflammatory, analgesic, quantitative structure–activity relationship and in vitro studies
    FAF Ragab, NM Abdel-Gawad, HH Georgey, MF Said
    2013

 

  • Synthesis and selective inhibitory effects of some 2-oxindole benzenesulfonamide conjugates on human carbonic anhydrase isoforms CA I, CA II, CA IX and CAXII
    RF George, MF Said, S Bua, CT Supuran
    2020

 

  • Synthesis, molecular modelling and QSAR study of new N-phenylacetamide-2-oxoindole benzensulfonamide conjugates as carbonic anhydrase inhibitors
    MF Said, RF George, A Petreni, CT Supuran, NM Mohamed
    2022

 

  • Synthesis and molecular docking of new imidazoquinazolinones as analgesic agents and selective COX-2 inhibitors
    HH Hassanein, HH Georgey, MA Fouad, AM El Kerdawy, MF Said
    2017

 

  • New NSAID conjugates as potent and selective COX-2 inhibitors: Synthesis, molecular modeling and biological investigation
    RM Bokhtia, SS Panda, AS Girgis, N Samir, MF Said, A Abdelnaser, …
    2023

 

  • Development of Isatin‐Based Schiff Bases Targeting VEGFR‐2 Inhibition: Synthesis, Characterization, Antiproliferative Properties, and QSAR Studies
    IA Seliem, SS Panda, AS Girgis, QL Tran, MF Said, MS Bekheit, …
    2022

 

  • Synthesis and computational studies of novel fused pyrimidinones as a promising scaffold with analgesic, anti-inflammatory and COX inhibitory potential
    MF Said, HH Georgey, ER Mohammed
    2021

 

  • Novel Curcumin Mimics: Design, Synthesis, Biological Properties and Computational Studies of Piperidone‐Piperazine Conjugates
    MA Youssef, SS Panda, DR Aboshouk, MF Said, A El Taweel, M GabAllah, …
    2022

 

✅ Conclusion

Through her unwavering dedication to pharmaceutical chemistry, Dr. Said has carved out a meaningful role in academia and research. Her work not only advances scientific understanding but also nurtures future innovators in the field. With a strong foundation in both teaching and research, and a vision for multidisciplinary innovation, she is poised to continue making impactful contributions to drug discovery and pharmaceutical education in the years to come.

Michael Leoncio | Neuroscience & Education | Best Researcher Award

Published on by Neuroscientists

Dr. Michael Leoncio | Neuroscience & Education | Best Researcher Award

Dr. Michael Leoncio, NIcklaus Childrne’s Hospital, United States.

Dr. Michael Leoncio is a dedicated pediatric critical care physician whose academic and professional journey reflects a deep passion for child health. Beginning with a dual degree in Chemistry and Physical Therapy, he went on to earn his D.O. from the New York College of Osteopathic Medicine. His clinical training took him from a pediatric residency in New Jersey to specialized fellowships at Miami Children’s Hospital, focusing on both general and cardiac pediatric critical care. Throughout his career, Dr. Leoncio has made significant contributions in the high-intensity environment of pediatric ICUs, shaping protocols, mentoring new clinicians, and improving outcomes for countless children.

Profile

Orcid

🎓 Early Academic Pursuits

Born in Hialeah, Florida, Dr. Michael Leoncio’s educational journey began with a strong dual foundation in Chemistry and Physical Therapy at the University of Miami, where he earned both his BHS and BA degrees. Driven by a passion for healing and science, he advanced to the New York College of Osteopathic Medicine, obtaining his Doctor of Osteopathy (D.O.) in 2004. These formative years were marked by his unwavering dedication to medicine and a growing interest in pediatric health, setting the stage for his future specialization in pediatric critical care.

🏥 Professional Endeavors

Following medical school, Dr. Leoncio completed a pediatric internship and residency at Newark Beth Israel Medical Center in New Jersey. His experiences under the mentorship of Dr. Josh Rosenblatt solidified his commitment to caring for children facing complex health challenges. He then pursued advanced fellowship training in Pediatric Critical Care Medicine from July 2007 to June 2010 at Miami Children’s Hospital, under Dr. Balaganghadar Totapally. Continuing his pursuit of excellence, he further specialized with an additional year as a Clinical Fellow in Pediatric Cardiac Critical Care Medicine, guided by Dr. Anthony Rossi. These rigorous training years provided Dr. Leoncio with extensive hands-on experience in managing critically ill children with cardiac conditions.

🔬 Contributions and Research Focus

Dr. Leoncio’s fellowship years were not only defined by clinical mastery but also by his engagement in cutting-edge pediatric and cardiac intensive care research. Working within high-acuity settings, he contributed to innovations in the care of neonates and children requiring intensive monitoring and support. His clinical insights have contributed to protocol advancements in cardiac intensive care, especially in the nuanced management of post-operative pediatric patients.

🏅 Accolades and Recognition

Throughout his academic and professional career, Dr. Leoncio has garnered recognition for his commitment to compassionate, evidence-based care. His peers and mentors have consistently praised his diligence, leadership qualities, and dedication to the field of pediatric critical care. These commendations reflect not only his technical expertise but also his empathetic approach to both patients and their families during the most vulnerable times.

Publication

  • Prevalence of Arginine Vasopressin Deficiency among Children and Adolescents Declared Dead by Neurologic Criteria
    Cesar Esteban Larancuent; Valandrea Merilan; Michael Leoncio; Juan Manuel Lozano; Balagangadhar R. Totapally | 2025

 

  • Epidemiology and outcomes of children with accidental hypothermia: A propensity-matched study
    Totapally A; Leoncio M; Beltramo F; Keith Meyer; Raszynski A; Totapally BR | 2017

 

  • Serial cardiac troponin concentrations as marker of cardiac toxicity in children with status asthmaticus treated with intravenous terbutaline
    Kalyanaraman M; Bhalala U; Leoncio M | 2011

 

  • Therapeutic hypercapnia enhances the inflammatory response to endotoxin in the lung of spontaneously breathing rats
    Norozian FM; Leoncio M; Torbati D; Keith Meyer; Raszynski A; Totapally BR | 2011

 

🏁 Conclusion

Driven by compassion, expertise, and a vision for innovation, Dr. Leoncio stands as a beacon in the field of pediatric medicine. His commitment to critical care continues to inspire those around him and set new standards for excellence in child health. As he looks to the future, his ongoing efforts promise to elevate pediatric intensive care—ensuring that every child, no matter how critically ill, receives the best possible chance at recovery and life.

EMRE MISIR | Cognitive Neuroscience | Young Scientist Award

Published on by Neuroscientists

Assist. Prof. Dr. EMRE MISIR | Cognitive Neuroscience | Young Scientist Award

Assist. Prof. Dr.  EMRE MISIR, Baskent University, Turkey.

Dr. Emre MISIR is a distinguished psychiatrist and neuroscience researcher, whose academic journey began at Adnan Menderes University and led to specialization in psychiatry at Dokuz Eylül University. His professional career includes serving as a Specialist Physician at Yozgat City Hospital before transitioning to an academic role at Başkent University Faculty of Medicine. Currently, he is pursuing a Ph.D. in Interdisciplinary Neuroscience at Ankara University, focusing on Theory of Mind in Obsessive-Compulsive Disorder (OCD). His outstanding exam scores, professional memberships, and active research contributions underscore his dedication to advancing psychiatry.

Profile

Orcid

Early Academic Pursuits 🎓

Born on July 16, 1989, in Şahinbey, Gaziantep, Turkey, Dr. Emre MISIR embarked on an academic journey rooted in a passion for medicine and mental health. He completed his medical education at Adnan Menderes University between 2006 and 2012, where his keen interest in the complexities of the human mind began to take shape. His dedication and academic excellence led him to pursue a specialization in psychiatry at Dokuz Eylül University Faculty of Medicine, where he trained extensively from 2012 to 2017.

Professional Endeavors 🏥

Following his specialization, Dr. MISIR served as a Specialist Physician at Yozgat City Hospital from 2017 to 2020, providing essential mental health care to diverse patient populations. In July 2020, he transitioned to Başkent University Faculty of Medicine, where he continued his professional practice before taking on a more academic role. By April 2020, his expertise and commitment to education earned him a Lecturer position at Başkent University, where he has been actively involved in mentoring young psychiatrists and medical students.

Contributions and Research Focus 🔬

With a profound interest in the intersection of psychiatry and neuroscience, Dr. MISIR has dedicated his research to understanding complex cognitive and psychological disorders. Currently pursuing a doctoral program in Interdisciplinary Neuroscience at Ankara University, his research explores the intricate mechanisms underlying obsessive-compulsive disorder (OCD). His thesis, titled “Theory of Mind in Patients with Obsessive-Compulsive Disorder: Relationship with Cognitive Functions, Overvalued Ideas, Insight, Schizotypal Personality Traits, and Other Clinical Characteristics,” under the supervision of Prof. Dr. Berna Binnur Kıvırcık Akdede, sheds light on the cognitive and neurobiological factors influencing psychiatric conditions.

Accolades and Recognition 🏅

Dr. MISIR’s commitment to academic excellence is reflected in his outstanding achievements in competitive examinations. His remarkable performance in the TUS Clinical Exam (Fall 2012) with a rank of 101, and his high ALES Numerical score of 88.58 demonstrate his academic rigor. Additionally, his proficiency in English, certified by a YÖKDİL score of 88.75, further amplifies his ability to contribute to international research and collaboration in psychiatry and neuroscience.

Impact and Influence 🌍

Beyond clinical practice and academia, Dr. MISIR is an active member of key professional organizations, including the Turkish Psychiatric Association, the Cognitive Behavioral Psychotherapy Association, and the Clinical Neuropsychopharmacology Association, where he serves as the Treasurer. His contributions to these organizations reflect his dedication to advancing psychiatric research and improving mental health treatments in Turkey and beyond. Through his engagement in professional networks, he has been instrumental in fostering interdisciplinary collaboration and promoting evidence-based psychiatric practices.

Legacy and Future Contributions 🚀

As a psychiatrist, researcher, and educator, Dr. MISIR continues to push the boundaries of neuroscience and psychiatric research. His work not only enhances the understanding of cognitive disorders but also paves the way for more effective diagnostic and therapeutic approaches. With his ongoing doctoral research and contributions to academic literature, he aspires to shape the future of psychiatric treatment, integrating neurobiological insights with clinical practice. His unwavering dedication to mental health and neuroscience ensures that his influence will extend beyond his current academic and clinical roles, leaving a lasting impact on the field.

Publication

  • Clinical Characteristics of Cognitive Subgroups of Obsessive Compulsive Disorder

    • Authors: Emre Mısır, Raşit Tükel, Berna Binnur Akdede, Emre Bora

    • Year: 2025

 

  • Validity and Reliability Study of the Turkish Form of the 4th Version of the Mental Illness: Clinicians’ Attitudes (MICA) Scale

    • Authors: Emre Mısır, Yasemin Hosgören Alıcı, Zeynep Bozkurt, Hüseyin Batuhan Elhan

    • Year: 2024

 

  • Functional connectivity in rumination: a systematic review of magnetic resonance imaging studies

    • Authors: Emre Mısır, Yasemin Hoşgören Alıcı, Orhan Murat Kocak

    • Year: 2023

 

  • Synaptic dysfunction in schizophrenia

    • Authors: Emre Mısır, Güvem Gümüş Akay

    • Year: 2023

 

  • The effects of catechol‐O‐methyltransferase single nucleotide polymorphisms on positive and negative symptoms of schizophrenia: A systematic review and meta‐analysis

    • Authors: Emre Misir, Mutlu Muhammed Ozbek, Eren Halac, Serkan Turan, Gokce Elif Alkas, Remzi Ogulcan Ciray, Cagatay Ermis

    • Year: 2022

 

  • DSM-5 Anksiyöz Distres Değerlendirme Ölçeği Türkçe Formunun Major Depresif Bozukluk için Geçerlilik ve Güvenilirlik Çalışması

    • Authors: Emre Mısır

    • Year: 2020

 

  • Reliability and validity of the Turkish Version of DSM-5 Anxious Distress Rating Scale for major depressive disorder

    • Authors: Misir, Emre; Hacimusalar, Yunus

    • Year: 2020

 

  • THE BRIEF RESIDENT WELLNESS PROFILE: VALIDITY AND RELIABILITY OF TURKISH VERSION

    • Authors: Misir, Gamze Akyol; Balik, Gurcan; Misir, Emre; Kartal, Mehtap

    • Year: 2020

 

  • The concept of schizotypy and schizotypal personality disorder

    • Authors: Misir, Emre; Alptekin, Koksal

    • Year: 2020

 

Conclusion 🌟

Dr. MISIR’s career embodies a commitment to merging clinical expertise with neuroscience research to enhance the understanding and treatment of psychiatric disorders. His contributions to academia, professional organizations, and clinical practice solidify his role as an influential figure in modern psychiatry. As he continues to explore the intricate mechanisms of mental health, his work promises to shape the future of psychiatric care and inspire the next generation of researchers and clinicians. His journey is one of excellence, innovation, and unwavering dedication to mental health and neuroscience.